Our Organization Relation Therapeutics, Ltd.
Our Organization Relation Therapeutics, Ltd.
Lavender Swirl Background

Relation Therapeutics, Ltd.

Relation Therapeutics, Ltd. is here to leverage the most powerful machine learning techniques currently being deployed in some of the world’s largest tech companies and academia.

Relation Therapeutics, Ltd. uses cutting edge machine learning technology to find unknown relationships between drugs and disease processes. They then generate predictions for novel drug repurposing candidates, with a view to rapidly progressing them through to the clinic.

Relation engages in fundamental model innovation, source unique data and find novel application areas, adapting these methods to unsolved problems in biology. Specifically, Relation identifies and develops the repositioning of therapeutics to improve outcomes for patients with age-related diseases.

Relation’s researchers strive daily to remain ‘bilingual’: equally conversant with the current state-of-the-art in data science and machine learning and with the biology and drug development expertise essential to bring therapeutics to patients in record time.

In the News

Relation Therapeutics

Longevity Technology: 'Relation-Mila collaboration wins $1.3m Gates Foundation Award to fight COVID-19'

Relation Therapeutics and Mila, the Montreal-based AI research institute are collaborating on a new project targeting the development of COVID-19 therapeutics funded by the Bill & Melinda Gates Foundation.

September 1, 2020

Read More
Relation Therapeutics

Relation Therapeutics Receives $1.3M Grant From the Gates Foundation to Identify Covid-19 Therapeutic Candidates

Relation Therapeutics, announces Project RE, which will apply Relation Therapeutics’ and its partners’ technology to the identification of repurposed drug combinations as potential therapeutic candidates for COVID-19.

August 31, 2020

Read More

Contact Us

We are here to help answer any questions you might have.